Anastrozole Tablet
Product Images NDC 24979-725

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 24979-725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure For Anastrozole (Image 01)

Chemical structure of anastrozole, the active ingredient in Anastrozole Tablets 1 mg. The diagram shows the molecular configuration with a triazole ring and substituted benzene ring with nitrile and methyl groups.*

FDA Label Image

Figure 1 (Image 02)

A survival curve chart comparing disease-free survival in months between patients treated with anastrozole or tamoxifen. The y-axis shows the proportion of patients alive and disease-free, ranging from 0.0 to 1.0, while the x-axis shows disease-free survival time in months up to 90. The chart includes the number of patients at risk over time for both treatments.*

FDA Label Image

Figure 2 (Image 03)

A survival curve chart showing disease-free survival over time in months for patients treated with anastrozole and tamoxifen. The y-axis indicates the proportion of patients alive and disease-free, decreasing from 1.0 to about 0.75 over 90 months. The x-axis presents disease-free survival in months from 0 to 90. Two lines represent treatment groups: a dashed line for anastrozole and a solid line for tamoxifen, with patient numbers at risk listed below for various time points.*

FDA Label Image

Figure 3 (Image 04)

A Kaplan-Meier survival curve chart comparing Anastrozole and Tamoxifen treatments over time up to 120 months. The y-axis shows the proportion event-free, while the x-axis represents time to event in months. The number of patients at risk is listed below the chart for both treatments at various time points.*

FDA Label Image

Figure 4 (Image 05)

Kaplan-Meier survival curves comparing the proportion event-free over time (up to 120 months) for patients treated with Anastrozole versus Tamoxifen. The x-axis shows time to event in months and the y-axis shows the proportion event free. The number of patients at risk at various time points is listed below the graph for both treatment groups.*

FDA Label Image

Figure 5 (Image 06)

A Kaplan-Meier curve comparing time to progression (months) between Anastrozole and Tamoxifen treatments. The graph plots proportion progression-free over time, with Anastrozole represented by a solid line and Tamoxifen by a dashed line. A table below shows the number of patients at risk at various time points for each treatment group.*

FDA Label Image

Figure 6 (Image 07)

A Kaplan-Meier survival curve chart depicting the proportion of patients not progressing over time in months, comparing two treatments: Anastrozole (solid line) and Tamoxifen (dashed line). The x-axis represents time to progression in months, and the y-axis shows the proportion not progressing. Patient numbers at risk are listed below the timeline.*

FDA Label Image

30's (Label30)

Label for Anastrozole Tablets, USP 1 mg by Upsher-Smith Laboratories, LLC featuring a quantity of 30 tablets. Manufactured by Bora Pharmaceutical Services Inc., the label includes usage and storage instructions, a barcode, and Rx only designation. The NDC on the label is 24979-725-06.*

FDA Label Image

90's (Label90)

Anastrozole Tablets, USP 1 mg oral tablets label displaying the product name and strength prominently. The label indicates the package contains 90 tablets and is Rx only. It includes manufacturer information for TW Pharmaceuticals USA, Inc. and Bora Pharmaceutical Services Inc., as well as storage instructions at controlled room temperature. The NDC 24979-725 and barcode are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.